News
Under the agreement, Pharmaron will validate CN Bio’s PhysioMimix ® technology across existing applications and collaborate on integrating OOC technologies into its R&D platform.
CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, today announced a strategic partnership with SCINCO, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback